Stay updated on OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial
Sign up to get notified when there's something new on the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page.

Latest updates to the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a new Locations section with study sites in California, Ohio, and Pennsylvania. The page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.4%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now shows Revision: v3.3.2 instead of v3.3.1. This is a minor UI/version update and does not affect the study details.SummaryDifference0.1%

- Check45 days agoChange DetectedPubMed publication note text updated to indicate PubMed-derived publications; page revision updated to v3.3.1.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page no longer displays the government funding/operating status notice (related to NIH funding and cc.nih.gov updates). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedDate entries in the Study Record Dates were updated to include newer timestamps (2025-10 and 2025-11-04) and an 'Estimated Last Update Posted' entry was added. Older August timestamps (2025-08-01 and 2025-08-03) were removed.SummaryDifference0.3%

- Check67 days agoChange DetectedThere have been no additions or deletions to the Study Details page for NCT02286089. The page content remains focused on the safety and efficacy study of OpRegen for advanced dry-AMD.SummaryDifference0.5%

Stay in the know with updates to OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page.